MDCO
Until late Monday, Amarin continued to get good news relevant to Vascepa, its treatment for cardiovascular disease. The big news, though, was lurking in Nevada federal district court.
Published:
Medicines Co shares shot up on Monday after it was reported that Novartis will be acquiring the firm. The transaction was unanimously approved by the boards of directors of both companies.
Published:
Stocks were indicated to open higher on Monday after the Dow Jones Industrial Average and S&P 500 had pulled back after hitting all-time highs last week. The economic readings keep coming in...
Published:
Medicines shares shot up on Tuesday after it was reported that Novartis might be eyeing this company as its newest acquisition.
Published:
These three biotech stocks have upcoming clinical data and presentations that could be huge, and they could blast the stocks higher.
Published:
Medicines Co. shares made a handy gain on Tuesday after the firm announced results from its late-stage trial in the treatment of low-density lipoprotein cholesterol.
Published:
The top analyst upgrades, downgrades and initiations for Tuesday included Annaly Capital Management, Amazon.com, Enterprise Products Partners, Kinder Morgan, Lululemon Athletica, RealReal, Snap,...
Published:
Medicines Company shares jumped early on Monday after the firm announced results from its late-stage cholesterol study of inclisiran.
Published:
The top analyst upgrades, downgrades and initiations seen on Friday included Amazon.com, Aurora Cannabis, Cleveland-Cliffs, FedEx, Ferrari, Grubhub, Hexo, Proofpoint, Shutterfly and Starbucks.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included Bunge, Cheniere Energy, FedEx, Kinder Morgan, Micron Technology, Monster Beverage, Teva Pharmaceutical and Western...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included Apple, ConocoPhillips, Internap, Micron Technology, Steelcase, Vulcan Materials and Wipro.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included Arena Pharmaceuticals, Autodesk, Coca-Cola, General Electric, Marvell, Monster Beverages, Nabors and Procter &...
Published:
Last Updated:
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday, January 6, include Cognizant Technology Solutions, Etsy, GoPro, Illumina, Shake Shack and Travelers Companies.
Published:
Last Updated:
A new Jefferies research report makes the case that five top biotech companies may be right in the cross-hairs of the biotech giants or perhaps large pharmaceutical companies.
Published:
Last Updated: